VpCI™ CorrLube® Grease TYPICAL APPLICATIONS • Metal-to-metal • Lubricating sleeves • Ball and roller bearings • Vehicle / equipment chassis • Fans • Areas greases are applied • Bushings • Pulley bearings • Sliding high-friction areas • Generator end bearings PRODUCT DESCRIPTION ADVANTAGES
VpCI CorrLube is a lithium complex grease formulated
• Cleaner application; decreases dripping and spattering
with premium quality, severely hydrotreated base stock. It
provides excellent resistance to oxidation and has good
• Greases can provide lubrication for longer periods of
high temperature stability. VpCI CorrLube is suitable for
both operating and lay-up conditions.
• Greases make seals more effective to keep
VpCI CorrLube is specifically formulated with superior
• Excellent for intermittent operation.
corrosion inhibiting properties against salt water, brine,
• Aids in the suspension of solid additives such as
H S, HCl and other corrosive agents. In addition, it
graphite, molybdenum, disulfide, etc.
incorporates vapor phase corrosion inhibitors for areas
• Effective in extreme operating conditions (i.e. high
temperature, high pressure, low speed/high pressure, and shock loading). PHYSICAL PROPERTIES
• Thicker film allows for operation on worn parts.
• Thick films provide surface protection against movement
METHOD OF APPLICATION • Brushing, grease gun or automatic applicator. • Temperature range: -22º to 266ºF (-30º to 130ºC). PACKAGING AND STORAGE • Minimum storage temperature: 0ºF (-18ºC) • Maximum storage temperature: 120ºF (49ºC).
This product is available in 14.5 ounce cartridges (10 per case). It also available in 5 gallon (19 liters) pails and 55 gallons (208 liters) drums. FOR INDUSTRIAL USE ONLY KEEP OUT OF REACH OF CHILDREN KEEP CONTAINER TIGHTLY CLOSED NOT FOR INTERNAL CONSUMPTION CONSULT MATERIAL SAFETY DATA SHEET FOR MORE INFORMATION LIMITED WARRANTY
All statements, technical information and recommendations contained herein are based on tests Cortec Corporation
BEFORE USING, USER SHALL DETERMINE THE SUITABILITY OF THE PRODUCT FOR ITS INTENDED
believes to be reliable, but the accuracy or completeness thereof is not guaranteed. USE, AND USER ASSUMES ALL RISK AND LIABILITY WHATSOEVER IN CONNECTION THEREWITH. No representation or recommendation not contained herein shall have any force or effect unless in a written document
Cortec Corporation warrants Cortec® products will be free from defects when shipped to customer. Cortec
signed by an offi cer of Cortec Corporation.
Corporation’s obligation under this warranty shall be limited to replacement of product that proves to be defective. To obtain replacement product under this warranty, the customer must notify Cortec Corporation of the claimed
THE FOREGOING WARRANTY IS EXCLUSIVE AND IN LIEU OF ALL OTHER WARRANTIES, EXPRESS, IMPLIED
defect within six months after shipment of product to customer. All freight charges for replacement products
OR STATUTORY, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTY OF MERCHANTABILITY OR OF FITNESS FOR A PARTICULAR PURPOSE. IN NO CASE SHALL CORTEC CORPORATION BE LIABLE FOR INCIDENTAL OR CONSEQUENTIAL DAMAGES.
Cortec Corporation shall have no liability for any injury, loss or damage arising out of the use of or the inability to use the products.
4119 White Bear Parkway, St. Paul, MN 55110 USAPhone (651) 429-1100, Fax (651) 429-1122Toll Free (800) 4-CORTEC, E-mail [email protected] http://www.CortecVpCI.com
Revised 5/1/06. Cortec Corporation 2001-2006. All rights reserved. Supersedes:10/9/01.
2001-2006, Cortec Corporation. All Rights Reserved. Copying of these materials in any form
without the written authorization of Cortec Corporation is strictly prohibited.
BIOMEDICAL CHROMATOGRAPHY Biomed. Chromatogr. 14 : 219–226 (2000) Determination of Ibuprofen in human plasma by high-performance liquid chromatography: validation andR. Canaparo1*, E. Muntoni1, G. P. Zara1, C. Della Pepa1, E. Berno1, M. Costa2 and M. Eandi11Department of Anatomy, Pharmacology and Forensic Medicine, University of Torino, Torino, Italy2Department of Electronics, Polythecn
Thu, 14 Aug 2008 15:00:32 +0200 [08/14/08 08:00PM ICT] To: Subject: Fw: Microbial Drug Resistance Priority: 1 Part(s): Headers: Dear Dung, could you please reply to my email and answer the questions of reviewer n°2 mentioned in his/her minor comments: Materials and methods 1) Bacterial strains: Please give information on how representative the sample is for all the E. ictaluri is